- Home
- HOUR vs GANX Comparison
HOUR vs GANX Comparison
Compare HOUR & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- GANX
- Stock Information
- Founded
- HOUR 2015
- GANX 2017
- Country
- HOUR United States
- GANX United States
- Employees
- HOUR N/A
- GANX N/A
- Industry
- HOUR Catalog/Specialty Distribution
- GANX Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- GANX Health Care
- Exchange
- HOUR Nasdaq
- GANX Nasdaq
- Market Cap
- HOUR 47.1M
- GANX 53.8M
- IPO Year
- HOUR 2022
- GANX 2021
- Fundamental
- Price
- HOUR $1.61
- GANX $1.72
- Analyst Decision
- HOUR
- GANX Strong Buy
- Analyst Count
- HOUR 0
- GANX 5
- Target Price
- HOUR N/A
- GANX $8.20
- AVG Volume (30 Days)
- HOUR 427.9K
- GANX 299.5K
- Earning Date
- HOUR 08-08-2025
- GANX 08-07-2025
- Dividend Yield
- HOUR N/A
- GANX N/A
- EPS Growth
- HOUR N/A
- GANX N/A
- EPS
- HOUR 0.01
- GANX N/A
- Revenue
- HOUR $139,408,829.00
- GANX N/A
- Revenue This Year
- HOUR N/A
- GANX N/A
- Revenue Next Year
- HOUR N/A
- GANX N/A
- P/E Ratio
- HOUR $234.09
- GANX N/A
- Revenue Growth
- HOUR 2.71
- GANX N/A
- 52 Week Low
- HOUR $0.83
- GANX $0.89
- 52 Week High
- HOUR $6.90
- GANX $3.19
- Technical
- Relative Strength Index (RSI)
- HOUR 62.63
- GANX 49.29
- Support Level
- HOUR $1.46
- GANX $1.55
- Resistance Level
- HOUR $1.74
- GANX $1.79
- Average True Range (ATR)
- HOUR 0.17
- GANX 0.16
- MACD
- HOUR 0.02
- GANX -0.00
- Stochastic Oscillator
- HOUR 35.59
- GANX 44.53
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.